Note: This company is no longer actively listed. Financial data shown is historical.
Key market metrics for J.B. Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) listed on NSE. For pharmaceuticals sector companies, these metrics provide a snapshot of J.B. Chemicals & Pharmaceuticals Ltd.'s market valuation and enterprise value, essential for comparing against intrinsic value estimates.
We analyze J.B. Chemicals & Pharmaceuticals Ltd. using multiple valuation models appropriate for PHARMACEUTICALS companies. For PHARMACEUTICALS companies, we use P/E Ratio Analysis, Discounted Cash Flow (DCF), and EPS Growth Valuation to determine fair value estimates for J.B. Chemicals & Pharmaceuticals Ltd. stock.
10-year Price-to-Earnings ratio trend
Current P/E Ratio
54.19
Jul 16, 2026
5-Year Median P/E
42.21
5-Year Historical Median
Difference
11.98
28.4%
Analysis: J.B. Chemicals & Pharmaceuticals Ltd.'s current P/E ratio is 28.4% above its 5-year median, suggesting the stock may be overvalued relative to its historical earnings performance.
The P/E ratio measures how much investors pay for each rupee of earnings (Share Price / EPS). A higher PE suggests the market expects strong future growth, while a lower PE may indicate undervaluation or slower growth prospects. Compare J.B. Chemicals & Pharmaceuticals Ltd.'s current PE against its historical median and PHARMACEUTICALS peers to gauge whether the stock is trading at a premium or discount relative to its earnings.
Go beyond charts — get fair value estimates from multiple valuation models and detailed assessment breakdowns.
Billed annually
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2026